MicroCloud Hologram Inc. (NASDAQ: HOLO) had a rollercoaster ride last week, witnessing a significant 40% decline on Friday, only to bounce back impressively with a surge of over 60% in premarket trading on Monday. The Surge’s Origin HOLO’s sudden resurgence coincides with an extraordinary surge in trading volume, as 50% of its total float exchanged […]
MicroCloud Hologram (HOLO) Sees Remarkable Premarket Recovery Read More »
Li Auto Inc. (NASDAQ: LI) navigated a tepid Friday, experiencing a minor dip of 0.54%. However, Monday’s early premarket hours witnessed an impressive surge of 9.2%, fueled by the unveiling of robust financial results. Financial Performance Li Auto, Inc., a prominent player in China’s electric vehicle sector, disclosed its impressive financial achievements in its latest
Li Auto Inc. Rockets Up Following Strong Financial Showing Read More »
Semilux International Ltd. (NASDAQ: SELX) faced a turbulent week as its stock plummeted by 21% on Friday, followed by another 12.3% drop in premarket trading on Monday. Despite the downturn, the company remains focused on its strategic initiatives in the optical and 3D sensing technology sector. Strategic Investment for Growth Semilux recently announced a common
Semilux International (SELX) Navigates Volatility with Strategic Equity Deal Read More »
Shares of Kintara Therapeutics, Inc. (Nasdaq: KTRA) experienced a sluggish trading session on Friday, dipping nearly 5%. However, the pre-market session today hints at a slight rebound, showing a 2% increase. Key Corporate Updates Kintara, a company specializing in cancer therapies, recently unveiled significant developments: Initiation of REM-001 Study Kintara commenced an open-label study evaluating
Kintara Therapeutics (KTRA) Sees Market Recovery Post Friday Downturn Read More »
Nuwellis, Inc. (Nasdaq: NUWE) saw a modest 1.83% increase in trading on Friday. However, today’s premarket session reveals a significant uptick of 10%, indicating promising developments for investors. Advancing Pediatric Care Nuwellis, a medical technology company based in Minneapolis, focuses on enhancing patient outcomes, particularly for those grappling with fluid overload. Their flagship product, the
Nuwellis, Inc. (NUWE) Climbs High with FDA Approval for Quelimmune Read More »
NeuBase Therapeutics (NASDAQ: NBSE), a notable player in genetic neurological disorder treatments, experienced a bumpy ride in the stock market last Friday. Initially taking a nosedive by 7.51%, the stock made a dramatic rebound over the weekend, surging an astonishing 42% during after-hours trading. Such volatility left investors scratching their heads, pondering the underlying reasons
NeuBase Therapeutics (NBSE) Faces Uncertain Future Despite After-Hours Surge Read More »
ZyVersa (Nasdaq: ZVSA), a leading biopharmaceutical company focusing on renal and inflammatory diseases, witnessed a remarkable surge in its stock price following the release of its latest white paper. Investors have been buoyed by the promising prospects outlined in the document, propelling the stock to new heights, especially in the after-hours session. White Paper Unveils
ZyVersa’s Breakthrough: Promising Advances in Neurological Disease Treatment Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.